Mohammed Badedi

Dr. Mohammed Badedi

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2016 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
MBMohammed Badedi
Mohammed Badedi
YSyahia solan
yahia solan
HDHussain Darraj
Hussain Darraj
ASAbdullah Sabai
Abdullah Sabai
MMMohamed Salih Mahfouz
Mohamed Salih Mahfouz
AAAbdullah Alsabaani
Abdullah Alsabaani
Aims.This study assessed factors associated with glycemic control among Saudi patients with Type 2 diabetes mellitus (T2DM).Methods.We conducted an analytical cross-sectional study, which included a random sample of 288 patients with T2DM proportional to the diabetes population of each primary health care center in Jazan city, Kingdom of Saudi Arabia.Results.More than two-thirds (74%) of patients had poor glycemic control. Lack of education, polypharmacy, and duration of diabetes ≥ 7 years were significantly associated with higher glycated hemoglobin (HbA1c). Moreover, patients who were smoker or divorced were significantly more likely to have higher HbA1c. The patients who did not comply with diet or take their medications as prescribed had poor glycemic control. The study found lower HbA1c levels among patients who received family support or had close relationship with their physicians. Similarly, knowledgeable patients towards diabetes or those with greater confidence in ability to manage self-care behaviors had a lower HbA1c. In contrast, risk factors such as depression or stress were significantly correlated with poorer glycemic control.Conclusion.The majority of T2DM patients had poor glycemic control. The study identified several factors associated with glycemic control. Effective and tailored interventions are needed to mitigate exposure to these risk factors. This would improve glycemic control and reduce the risks inherent to diabetes complications.

1 May 2020 in Psychology Research and Behavior Management
Verified
Journal Article
Open access
PDF file
TATurki Alzughbi
Turki Alzughbi
MBMohammed Badedi
Mohammed Badedi
HDHussain Darraj
Hussain Darraj
AHAbdulrahman Hummadi
Abdulrahman Hummadi
SJSattam Jaddoh
Sattam Jaddoh
ASAbdullah Sabai
Abdullah Sabai
Objective: This study aims to assess the prevalence of diabetes mellitus (DM)-related distress and depression and their associated factors in Saudi people with type 2 DM (T2DM) in Jazan, Saudi Arabia. It also aims to assess the association between glycemic control and DM-related distress and depression. Methods: This is an analytical, cross-sectional study which recruited 300 Saudi patients with T2DM randomly from primary healthcare centers in Jazan, Saudi Arabia. DM-related distress and depression were measured by valid questionnaires, the 17-item Diabetes Distress Scale and the Patient Health Questionnaire-9, respectively. Logistic regression and an independent t-test were performed in the statistical analysis. Results: The mean age of the study population was 52.7 years, with a range of 23– 83 years. The number of males was 147 (49%) and females was 153 (51%) in the study population. The prevalence of DM-related distress and depression in Saudi patients with T2DM in Jazan was 22.3% and 20%, respectively, and about 7.7% had both. Of DM-related distress, 12.3% had interpersonal-related DM distress, 11.7% had physician-related DM distress, 10.7% had emotional-related DM distress, and 7% had regimen-related DM distress. After adjusting for covariates, being female, patients aged < 45, physical inactivity, DM duration < 5 years, and smoking were significantly associated with DM-related distress and depression. There was also a significant association between DM-related distress and depression, OR = 3 [95% CI: 1.8, 6.4]. Furthermore, we found that glycated hemoglobin (A1C) levels were significantly higher in those with DM-related distress (small effect size, eta squared = 0.04) and depression (moderate effect size, eta squared = 0.06) (P < 0.001). Conclusion: DM-related distress and depression are prevalent in patients with T2DM in Jazan, Saudi Arabia. Both these conditions need to be screened for and addressed in clinical settings. Establishing the causality of DM-related distress and depression in T2DM is an important aim for any future studies.

1 February 2020 in Diabetes, Metabolic Syndrome and Obesity
Verified
Journal Article
Open access
PDF file
MBMohammed Badedi
Mohammed Badedi
HDHussain Darraj
Hussain Darraj
AHAbdulrahman Hummadi
Abdulrahman Hummadi
ANAbdullah Najmi
Abdullah Najmi
YSYahiya Solan
Yahiya Solan
EHEbrahim Haddad
Ebrahim Haddad
Objective: Knowledge about the effects of khat chewing on type 2 diabetes mellitus (T2DM) development and glycemic control is very sparse. Emerging data suggest that khat chewing may increase the risk of T2DM occurrence. Therefore, this study aimed to measure the prevalence of khat chewing in Saudi people with T2DM in Jazan, Saudi Arabia and to determine the association of khat chewing with T2DM development and glycemic control in T2DM. Methods: This is an analytical, cross-sectional study that included 472 Saudi participants selected randomly from primary healthcare centers in Jazan, Saudi Arabia. A chi-square test and logistic regression were performed in the statistical analysis. Results: The prevalence of khat chewing in Saudi patients with T2DM in Jazan was 29.3%. After adjusting for covariates, khat chewing was significantly associated with T2DM (odds ratio 3.5), indicating that khat chewers had a more than three times higher risk of developing T2DM than those who do not chew khat. However, there was no association between khat chewing and glycemic control in T2DM. Conclusion: Khat chewing was highly prevalent in Saudi people with T2DM in Jazan, Saudi Arabia. There was an association between khat chewing and the development of T2DM. Establishing the causal association of khat chewing with T2DM development and glycemic control and clarifying the biological role of khat in T2DM are important aims for future studies.

1 December 2019 in Diabetes, Metabolic Syndrome and Obesity
Verified
Journal Article
Open access
PDF file
MBMohammed Badedi
Mohammed Badedi
HDHussain Darraj
Hussain Darraj
AHAbdulrahman Hummadi
Abdulrahman Hummadi
YSYahia Solan
Yahia Solan
IZIbrahim Zakri
Ibrahim Zakri
ABAhmed Budaydi
Ahmed Budaydi
Objective: To assess the association between vitamin B12 deficiency and the development of diabetic foot ulcers (DFU) in type 2 diabetes mellitus (T2DM). Methods: This is a case–control study that enrolled 323 Saudi adults with T2DM randomly selected from the Jazan Diabetes & Endocrine Center, Saudi Arabia from January 1, 2019, to July 31, 2019. The sample included 108 newly diagnosed cases with DFU and 215 control participants with T2DM unaffected by and free of foot ulcers (1:2 ratio). Logistic regression analysis was performed to determine the DFU predictors and to examine the association of DFU and vitamin B12 deficiency. Results: The highest DFU rates were found among the male participants and the participants older than 45 years. Neuropathy, vasculopathy, vitamin B12 deficiency, poor glycemic control, poor feet self-care, Charcot foot, physical inactivity, and spending long time standing at work were significantly associated with DFU, and all except physical inactivity and spending long time standing at work were independent predictors of DFU. After adjustment for the covariates, vitamin B12 deficiency was significantly associated with DFU (odds ratio 3.1), indicating that the patients with T2DM and vitamin B12 deficiency had a three times higher risk of developing DFU than those with normal vitamin B12 levels. Conclusion: Vitamin B12 deficiency had a significant association with DFU among the Saudi participants with T2DM. Establishing the causality and clarifying the biological role of vitamin B12 deficiency in DFU is important aims for future studies.

1 April 2021 in Journal of Infection and Public Health
Verified
Journal Article
Open access
MBMohammed Badedi
Mohammed Badedi
AMAli Makrami
Ali Makrami
AAAwaji Alnami
Awaji Alnami
The objective of the study was to assess mortality risk associated with co-morbidities and blood group type in coronavirus disease 2019 (COVID-19) patients in Jazan, Saudi Arabia. This case–control study enrolled 323 Saudi adults with COVID-19, confirmed by real-time reverse transcription–polymerase chain reaction. The participants were selected randomly between August 31, 2020, and July 1, 2020, from the Health Electronic Surveillance Network system, which contains the primary data on COVID-19 infections in Jazan, Saudi Arabia. The sample included 108 patients who died due to COVID-19 disease and 215 controls who recovered from it (1:2 ratio). The chi-square test, independent samples t-test, and logistic regression were used to perform the statistical analysis. Mortality was higher in older age patients with COVID-19 (mean = 65.4 years, standard deviation [SD] = 15.6) compared to recovered patients (mean = 39.5 years, SD = 14.8) (p < 0.001) with a moderate effect size (eta squared = 0.06). Diabetes mellitus (odds ratio [OR] = 9.4), hypertension (OR = 8.6), cardiovascular disease (OR = 7.4), chronic kidney disease (OR = 3.3), and obesity (OR = 2.0) were significantly associated with death due to COVID-19. Using logistic regression analysis, older age and diabetes mellitus were the primary independent predictors of COVID-19 mortality. However, there was no significant association between a specific ABO blood group and mortality risk (P = 0.07). Older age and the presence of co-morbidities, especially diabetes mellitus, increased the risk of death in patients with COVID-19. Establishing the causality of death in patients with COVID-19 should be a key aim of future studies.

1 July 2021 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
MBMohammed Badedi
Mohammed Badedi
HDHussain Darraj
Hussain Darraj
AAAwaji Qasem Alnami
Awaji Qasem Alnami
AMAli Makrami
Ali Makrami
MMMohamed Salih Mahfouz
Mohamed Salih Mahfouz
HMHalimh Mosa
Halimh Mosa
Objective: Fatalities due to coronavirus disease 2019 (COVID-19) continue to increase, and information on the epidemiological and clinical characteristics of deceased patients who were hospitalized with COVID-19 is limited in the Arab region. The current study aimed to address this gap. Methods: Three hundred and four Saudi patients in Jazan Region, Saudi Arabia, who died after being hospitalized with COVID-19 between July 1, 2020, and December 31, 2020, were analyzed in this retrospective cohort study. Results: A greater proportion of male patients (59%), compared to female patients (41%), died due to COVID-19. Just over half (55%) of the deaths due to COVID-19 affected patients aged ≥ 65 years. More than two-thirds of the deceased COVID-19 patients had diabetes (70%) and hypertension (69%); other comorbidities were obesity (30%), heart disease (30%), and chronic kidney disease (14%). Dyspnea (91%), cough (80%), and fever (70%) were the most frequently reported clinical symptoms. Eighty-five per cent of COVID-19 deaths occurred in patients admitted to the intensive care unit (ICU), and 90% of the patients required mechanical ventilation. Typically, lymphopenia, and neutrophilia were observed on admission and 24 hours prior to death. Creatinine and serum ferritin levels and erythrocyte sedimentation rate and D-dimer plasma levels increased significantly following infection with COVID-19. Lung infiltrates and pulmonary opacity (83%) were the most common findings on chest X-ray. Respiratory failure (70%) and acute respiratory distress syndrome (52%) were the leading complications to death. Logistic and Cox regression revealed that a higher age, smoking, high creatinine and aspartate transaminase levels, and respiratory failure were significantly associated with the risk of mortality during the early stay in hospitals. Conclusion: The proportion of comorbidities was high in deceased patients who were hospitalized with COVID-19 in Jazan region, Saudi Arabia. A higher age, smoking, and respiratory failure were significant predictors of mortality during the early stay in hospitals.